Key result
High shock index at NSTEMI presentation is linked to ~102% higher 28-day mortality.
Why the study?
Shock index is predictive of mortality in STEMI, but large-scale evaluations in patients with NSTEMI are lacking.
Does a high shock index at presentation predict 28-day mortality in patients hospitalized with NSTEMI?
Observational (n=18,301)
Yes
Does a high shock index at presentation predict 28-day mortality in patients hospitalized with NSTEMI?
A shock index ≥0.7 at presentation is a simple, easily obtainable metric that independently predicts 28-day mortality in patients with NSTEMI.
Answers are grounded in this paper and cite their sources.
May aid NSTEMI risk stratification; extends prior shock index data but remains hypothesis-generating.
AIMS: Shock index (SI), defined as the ratio of heart rate (HR) to systolic blood pressure (SBP), is easily obtained and predictive of mortality in patients with ST-segment elevation myocardial infarction. However, large-scale evaluations of SI in patients with non-ST-segment elevation myocardial infarction (NSTEMI) are lacking. METHODS AND RESULTS: Hospitalizations for acute myocardial infarction were sampled from four US areas by the Atherosclerosis Risk in Communities (ARIC) study and classified by physician review. Shock index was derived from the HR and SBP at first presentation and considered high when ≥0.7. From 2000 to 2014, 18 301 weighted hospitalizations for NSTEMI were sampled and had vitals successfully obtained. Of these, 5753 (31%) had high SI (≥0.7). Patients with high SI were more often female (46% vs. 39%) and had more prevalent chronic kidney disease (40% vs. 32%). TIMI (Thrombolysis in Myocardial Infarction) risk scores were similar between the groups (4.3 vs. 4.2), but GRACE (Global Registry of Acute Coronary Syndrome) score was higher with high SI (140 vs. 118). Angiography, revascularization, and guideline-directed medications were less often administered to patients with high SI, and the 28-day mortality was higher (13% vs. 5%). Prediction of 28-day mortality by SI as a continuous measurement [area under the curve (AUC): 0.68] was intermediate to that of the GRACE score (AUC: 0.87) and the TIMI score (AUC: 0.54). After adjustments, patients with high SI had twice the odds of 28-day mortality (odds ratio = 2.02; 95% confidence interval: 1.46-2.80). CONCLUSION: The SI is easily obtainable, performs moderately well as a predictor of short-term mortality in patients hospitalized with NSTEMI, and may be useful for risk stratification in emergency settings.
No takes yet. Share an insight, caveat, or question.
Chunawala et al. (2021) conducted an observational in non-ST-segment elevation myocardial infarction (NSTEMI) (n=18,301). High shock index (≥0.7) vs. Low shock index (<0.7) was evaluated on 28-day mortality (OR 2.02, 95% CI 1.46-2.80). High shock index (≥0.7) at presentation in patients with NSTEMI was associated with significantly higher 28-day mortality compared to low shock index (13% vs. 5%; OR 2.02; 95% CI 1.46-2.80).
Synapse has enriched 10 related papers. Consider them for comparative context: